Concepedia

Yingqing Liang

YL

Statistics

Publications

10

Citations

646

H-Index

10

Active since

2017

Affiliations

Fuda Cancer Hospital(Current)

Shenzhen Hanke Bioengineering (China)

Jinan University

First Affiliated Hospital of Jinan University

Lanzhou University of Technology

Yingqing Liang is an author at Fuda Cancer Hospital specializing in immunotherapy, oncology, and cancer immunotherapy.

Publications per year

2017–2025

10

Publications

10

Allogeneic Vγ9Vδ2 T-cell immunotherapy exhibits promising clinical safety and prolongs the survival of patients with late-stage lung or liver cancer

Yan Xu, Zheng Xiang, Mohammed Alnaggar et al. · Cellular and Molecular Immunology · 2020 · 251 citations · Full text

, , +17

Allogenic Vγ9Vδ2 T cell as new potential immunotherapy drug for solid tumor: a case study for cholangiocarcinoma

Mohammed Alnaggar, Yan Xu, Jingxia Li et al. · Journal for ImmunoTherapy of Cancer · 2019 · 128 citations · Full text

, , +14

Clinical efficacy of percutaneous cryoablation combined with allogenic NK cell immunotherapy for advanced non-small cell lung cancer

Mao Lin, Shuzhen Liang, Xiaohua Wang et al. · Immunologic Research · 2017 · 67 citations

, , +11

Comparison of autogeneic and allogeneic natural killer cells immunotherapy on the clinical outcome of recurrent breast cancer

Shuzhen Liang, Kecheng Xu, Lizhi Niu et al. · OncoTargets and Therapy · 2017 · 48 citations · Full text

, , +15

Tumor cryoablation in combination with natural killer cells therapy and Herceptin in patients with HER2-overexpressing recurrent breast cancer

Shuzhen Liang, Lizhi Niu, Kecheng Xu et al. · Molecular Immunology · 2017 · 41 citations

, , +16

1–5 of 10